No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs192908240 |
chr16:46663487-46663488 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs556925950 |
chr16:46663497-46663498 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs538815414 |
chr16:46663505-46663506 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs144608851 |
chr16:46663523-46663524 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs62060522 |
chr16:46663606-46663607 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs575375971 |
chr16:46663642-46663643 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs118085222 |
chr16:46663673-46663674 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs554226511 |
chr16:46663716-46663717 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs572788331 |
chr16:46663717-46663718 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs539894798 |
chr16:46663765-46663766 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs559973687 |
chr16:46663786-46663787 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs4966603 |
chr16:46663790-46663791 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
13 |
rs563558495 |
chr16:46663791-46663792 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs530863659 |
chr16:46663885-46663886 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs549468458 |
chr16:46663896-46663897 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs368322200 |
chr16:46663927-46663928 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs561269350 |
chr16:46663964-46663965 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs532195948 |
chr16:46663968-46663969 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs201000466 |
chr16:46663994-46663995 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs528484841 |
chr16:46664129-46664130 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs546708128 |
chr16:46664146-46664147 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs9935497 |
chr16:46664160-46664161 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
23 |
rs185119374 |
chr16:46664214-46664215 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs139002121 |
chr16:46664237-46664238 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs142277971 |
chr16:46664255-46664256 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs190444206 |
chr16:46664273-46664274 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs554646366 |
chr16:46664317-46664318 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs112832054 |
chr16:46664354-46664355 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs374662116 |
chr16:46664364-46664365 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs572878502 |
chr16:46664385-46664386 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs34106723 |
chr16:46664491-46664492 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs12933750 |
chr16:46664493-46664494 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs35012767 |
chr16:46664495-46664496 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs35124275 |
chr16:46664497-46664498 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs36065841 |
chr16:46664499-46664500 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs56309128 |
chr16:46664527-46664528 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs55720456 |
chr16:46664529-46664530 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs3932852 |
chr16:46664535-46664536 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
mRNA abundance
|
39 |
rs200671251 |
chr16:46664536-46664537 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs3932851 |
chr16:46664537-46664538 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs113107364 |
chr16:46664547-46664548 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs540715457 |
chr16:46664610-46664611 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs533764492 |
chr16:46664645-46664646 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs8057277 |
chr16:46664715-46664716 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs183885796 |
chr16:46664750-46664751 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs562089864 |
chr16:46664785-46664786 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs188217827 |
chr16:46664820-46664821 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs8053364 |
chr16:46664853-46664854 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
49 |
rs181391907 |
chr16:46664888-46664889 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs377641718 |
chr16:46664903-46664904 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|